Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay

Transfusion

Volumn 48, Issue 10, 2008, Pages 2133-2142

  Frietsch, Thomas ^a   Karger, Ralf ^b   Schöler, Michael ^b   Huber, Daniela ^b   Bruckner, Thomas ^b   Kretschmer, Volker ^b   Schmidt, Susanne ^b   Leidinger, Werner ^b   Weiler Lorentz, Arnulf ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; CEPHALOSPORIN; HEMOGLOBIN; IRON; NITRITE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASEPSIS; BLOOD AUTOTRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; INFECTION RATE; LENGTH OF STAY; LEUKAPHERESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TOTAL HIP PROSTHESIS; URINARY TRACT INFECTION; WOUND ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; CROSS INFECTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LENGTH OF STAY; LEUKOCYTE REDUCTION PROCEDURES; MALE; MIDDLE AGED; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 52949118769     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01804.x     Document Type: Article

References (38)

1. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994 84 : 1703 21.
2. Vamvakas EC. White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis. Vox Sang 2007 92 : 224 32.
3. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001 97 : 1180 95.
4. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion associated postoperative infection. Transfus Med Rev 2002 16 : 144 60.
5. Nielsen HJ. Clinical impact of bioactive substances in blood components: implications for leukocyte filtration. Infus Ther Transfus Med 1998 25 : 296 304.
6. Nielsen HJ. Influence on the immune system of homologous blood transfusion and autologous blood donation: impact on the routine clinical practice/differences in oncological and non-tumour surgery? Anasthesiol Intensivmed Notfallmed Schmerzther 2000 35 : 642 5.
7. Nielsen HJ. Transfusion-associated immunomodulation: experimental facts and clinical reality - new perspectives. Transfus Med Hemother 2006 33 : 324 9.
8. Ghio M, Ottonello L, Contini P, Amelotti M, Mazzei C, Indiveri F, Puppo F, Dallegri F. Transforming growth factor-beta1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Blood 2003 102 : 1100 7.
9. Ghio M, Contini P, Mazzei C, Merlo A, Filaci G, Setti M, Indiveri F, Puppo F. In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion? Transfusion 2001 41 : 988 96.
10. Frietsch T, Tolksdorf B, Nebe T, Segiet W, Lorentz A. Cellular immune response to autologous blood transfusion in hip surgery: whole blood vs packed red cells and plasma. Vox Sang 2001 81 : 187 93.
11. Tasaki T, Tasaki S, Gotoh K, Satoh S, Takadate J, Tachibana M, Suwabe A. The significance of prestorage leukoreduction of autologous blood. Transfusion 2003 43S : 133A.
12. Karger R, Stangenberg K, Hinrichs F, Griss P, Kretschmer V. Safety and efficacy of unmodified whole blood vs. buffy coat-depleted red cell concentrates in autologous transfusion of elective orthopaedic surgery patients. Transfus Med 2004 14 : 347 57.
13. Bundesärztekammer. Richtlinien für die Gewinnung von Blut und Blutbestandteilen und der Anwendung von Blutprodukten (Hämotherapie) 7/2000. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2000 43 : 555 89.
14. Karger R, Schmidt J, Weber C, Weiler-Lorentz A, Frietsch T, Kretschmer V. In-line filtration of autologous whole blood. Transfusion 2006 46 : 811 7.
15. Nadler R, Hidalgo JU, Bloch T. Prediction of blood volume in normal adult. Surgery 1962 62 : 224 32.
16. Byrne DJ, Malek MM, Davey PG, Cuschieri A. Postoperative wound scoring. Biomed Pharmacother 1989 43 : 669 73.
17. Wilson AP, Treasure T, Sturridge MF, Gruneberg RN. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet 1986 1 : 311 3.
18. Vamvakas EC, Carven JH. Transfusion of white-cell containing allogeneic blood components and postoperative wound infection: effect of confounding factors. Transfus Med 1998 8 : 29 36.
19. Farrer A, Spark JI, Scott DJ. Autologous blood transfusion: the benefits to the patient undergoing abdominal aortic aneurysm repair. J Vasc Nurs 1997 15 : 111 5.
20. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, Eissner HJ, Schildberg FW. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993 342 : 1328 33.
21. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991 31 : 212 7.
22. Triulzi DJ, Vanek K, Ryan DH, Blumberg N. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992 32 : 517 24.
23. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, Harvey MS, Huysmans HA, Brand A. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998 97 : 562 8.
24. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Møller-Nielsen C, Hanberg-Sørensen F, Hokland M. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992 79 : 513 6.
25. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996 348 : 841 5.
26. Frietsch T, Krombholz K, Tolksdorf B, Nebe T, Segiet W, Lorentz A. Cellular immune response to autologous blood transfusion in hip arthroplasty: whole blood versus buffy coat-poor packed red cells and fresh-frozen plasma. Vox Sang 2001 81 : 187 93.
27. Frietsch T, Fessler H, Kirschfink M, Nebe T, Waschke KF, Lorentz A. Immune response to autologous transfusion in healthy volunteers: WB versus packed RBCs and FFP. Transfusion 2001 41 : 470 6.
28. Tolksdorf B, Frietsch T, Quintel M, Kirschfink M, Becker P, Lorentz A. Humoral immune response to autologous blood transfusion in hip surgery: whole blood versus packed red cells and plasma. Vox Sang 2001 81 : 180 6.
29. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007 21 : 327 48.
30. Mijovic V, Brozovic B, Hughes AS, Davies TD. Leukocyte-depleted blood. A comparison of filtration techniques. Transfusion 1983 23 : 30 2.
31. Wenz B, Gurtlinger KF, O'Toole AM, Dugan EP. Preparation of granulocyte-poor red blood cells by microaggregate filtration: a simplified method to minimize febrile transfusion reactions. Vox Sang 1980 39 : 282 7.
32. Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002 325 : 652 4.
33. Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am 2003 85 : 27 32.
34. Williams O, Fitzpatrick R, Hajat S, Reeves BC, Stimpson A, Morris RW, Murray DW, Rigge M, Gregg PJ National Total Hip Replacement Outcome Study Steering Committee. Mortality, morbidity, and 1-year outcomes of primary elective total hip arthroplasty. J Arthroplasty 2002 17 : 165 71.
35. Anders MJ, Lifeso RM, Landis M, Mikulsky J, Meinking C, McCracken KS. Effect of preoperative donation of autologous blood on deep-vein thrombosis following total joint arthroplasty of the hip or knee. J Bone Joint Surg Am 1996 78 : 574 80.
36. Bae H, Westrich GH, Sculco TP, Salvati EA, Reich LM. The effect of preoperative donation of autologous blood on deep-vein thrombosis after total hip arthroplasty. J Bone Joint Surg Br 2001 83 : 676 9.
37. Karger R, Kretschmer V. The cost-effectiveness of autologous haemotherapy methods - an update and reappraisal. Transfus Alternat Transfus Med 2007 9 : 91 100.
38. Opitz A, Mainhardt C, Rendl J. In-vivo red blood cell recovery of leukocyte depleted whole blood. Infus Ther Transfus Med 2001 28 Suppl 1 : 20.